These findings demonstrate that TRPV4 activation promotes the metastasis of HCC in vivo, and GL-V9 effectively prevents HCC metastasis by inhibiting AMPK/MLC/ERM pathway implicated in sc polarity. Here, ETV5 is linked to hepatocellular carcinoma.